0
CollPlant Biotechnologies Ltd. Banner Image

CollPlant Biotechnologies Ltd. has reached its limit for free report views

Work for CollPlant Biotechnologies Ltd.? Upgrade Your Profile and unlock all your annual reports.

CollPlant Biotechnologies Ltd.

  • Ticker CLGN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CollPlant Biotechnologies Ltd. Logo Image
  • 11-50 Employees
  • Based in Rehovot, Israel
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. Their products are based on their rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. Their products address indications for the diverse fields of tissue repair, aesthetics and organMore manufacturing, and, they believe, are ushering in a new era in regenerative and aesthetic medicine. Their flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, they entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.
CollPlant Biotechnologies Ltd.

Most Recent Annual Report

CollPlant Biotechnologies Ltd. MOST RECENT 2019 Annual Report

Report Locked. CollPlant Biotechnologies Ltd. has reached its limit for free report views.

Older/Archived Annual Reports